| A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps (NCT05324137) | Keymed Biosciences Co.Ltd | 2022-07-11 |
| Real Life Study of Biologicals in Patients With Severe CRSwNP (NCT05938972) | University Hospital, Ghent | 2022-03-01 |
| Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis (NCT05246267) | Montefiore Medical Center | 2022-02-15 |
| BIOlogics in Severe Nasal POlyposis SurvEy (NCT05228041) | University Hospital, Lille | 2022-02-10 |
| Role of Montelukast in the Management of Chronic Rhinosinusitis With Nasal Polyps. (NCT05143502) | Assiut University | 2022-01-01 |
| The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps (NCT05131464) | Keymed Biosciences Co.Ltd | 2021-11-30 |
| 3D Printing to Improve Nasal Irrigation Outcome (NCT06118554) | Ohio State University | 2021-11-01 |
| Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52) (NCT05049122) | Sanofi | 2021-10-22 |
| Dupilumab in the Treatment of Severe Uncontrolled CRSwNP: a Multicentre Observational Real-life Study (DUPIREAL) (NCT05529784) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-10-06 |
| EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients (NCT04998604) | Sanofi | 2021-09-27 |
| Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps (NCT05009758) | Medical University of Vienna | 2021-09-01 |
| Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab) (NCT04823585) | Helsinki University Central Hospital | 2021-08-12 |
| Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis (NCT04869436) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2021-07-19 |
| Role of Doxycycline in Chronic Rhinosinusitis With Nasal Polyps (NCT05157412) | Assiut University | 2021-07-01 |
| A Study to Evaluate CBP-201, Rademikibart, in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps (NCT04783389) | Connect Biopharm LLC | 2021-06-16 |
| Dupilumab for Prevention of Recurrence of CRSwNP After ESS (NCT04596189) | Centre hospitalier de l'Université de Montréal (CHUM) | 2021-05-25 |
| The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic Rhinosinusitis (NCT05931744) | Kafrelsheikh University | 2021-05-01 |
| Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis (NCT04851964) | AstraZeneca | 2021-04-22 |
| Endoscopic Frontal Sinus Surgery Draf III in Moderate to Severe Eosinophilic Chronic Rhinosinusitis With Polyps (NCT05979662) | Ibrahim Talal Elshamy | 2021-01-01 |
| Preclinical Studies of Omalizumab in Chronic Rhinosinusitis With Nasal Polyposis (NCT04583501) | Johns Hopkins University | 2020-12-15 |
| Tissue Immune Interaction in Nasal Polyposis (NCT04628442) | University of California, San Francisco | 2020-11-10 |
| Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS (NCT04147013) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2020-02-18 |
| Comparing Budesonide Via MAD or INSI Prospective Cohort Study (NCT04267042) | St. Paul's Hospital, Canada | 2020-02-03 |
| Polysomnographic Findings in Nasal Polyposis (NCT03725956) | University Hospital, Lille | 2019-01-17 |
| Effect of Oral Vitamin D3 on Chronic Rhinosinusitis Treatment in Adults With Lower Vitamin D Levels (NCT02668861) | The First Affiliated Hospital of Shanxi Medical University | 2016-05-01 |
| Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis (NCT02743871) | Pfizer | 2016-04-27 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Chronic Rhinosinusitis With Nasal Polyps (NCT02170337) | Amgen | 2014-07-01 |